Clinical Trial Update: Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating mifepristone for posttraumatic stress disorder completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Stress Disorders, Post-Traumatic | Phase 2 | Status: COMPLETED | Results posted: 2018-01-24